Bartfeld Sina, Clevers Hans
Research Center for Infectious Diseases, ZINF, Institute for Molecular Infection Biology, IMIB, University of Würzburg, Josef-Schneider-Str 2/D15, 97080, Würzburg, Germany.
Hubrecht Institute, Uppsalalaan 8, 3584 CT, Utrecht, The Netherlands.
J Mol Med (Berl). 2017 Jul;95(7):729-738. doi: 10.1007/s00109-017-1531-7. Epub 2017 Apr 8.
3D culture has allowed the initiation and expansion of organ-like structures, called organoids, from either tissue-resident adult stem cells or pluripotent stem cells. Today, organoids can be grown to resemble a wide variety of organs, exhibiting remarkable similarity to their in vivo counterparts. As successful organoid generation is possible from virtually every patient, organoids hold a great promise for medical research and the development of new treatments. They have already found their way into the clinic, enabling personalized medicine in small patient trials. In this review, we provide an update on current organoid technology and summarize their application in basic research, disease modelling, drug development, personalized treatment and regenerative medicine.
三维培养技术已能够从组织驻留成体干细胞或多能干细胞起始并扩增出称为类器官的类器官样结构。如今,类器官能够培养得类似于多种器官,与其体内对应物表现出显著的相似性。由于几乎可以从每一位患者成功培养出类器官,类器官在医学研究和新疗法开发方面极具前景。它们已经进入临床,在小规模患者试验中实现了个性化医疗。在本综述中,我们提供了关于当前类器官技术的最新情况,并总结了它们在基础研究、疾病建模、药物开发、个性化治疗和再生医学中的应用。